A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.

DIAMOND is the first and only pivotal trial program ever conducted with a topical treatment for diabetic macular edema (DME) Over 800 patients randomized in DIAMOND-1 or DIAMOND-2 Phase 3 trials at an ...

PUDUCHERRY: In a major breakthrough, researchers at Pondicherry University have identified molecular markers in tear fluid ...

Bevacizumab may be preferable to ranibizumab in the treatment of retinopathy of prematurity in as far as it is associated with a lower risk of retreatment.

GLP-1 receptor agonists were associated with improved survival and reduced graft loss among kidney transplant recipients with type 2 diabetes.

Below a specific threshold, FCP exerts a protective effect, but above that threshold the protective effect becomes uncertain.

Researchers from the University of Bern analyzed over 300,000 FDA reports and found semaglutide use was linked to a higher ...

Managing diabetes complications remains a critical challenge, with macrovascular and microvascular conditions such as ...

Scientists have for the first time looked deep into the protein structure that may determine our vision - and discovered that ...

Diabetic retinopathy affects 30 lakh Indians and can lead to vision loss. Advanced therapies include costly injections ...

Scientists have for the first time looked deep into the protein structure that may determine our vision—and discovered that ...